演变的新辅助,辅助和同时系统治疗策略在头部和部状癌
1Department of Medical Oncology, 1006, Homi Bhabha Block, Tata Memorial Hospital, Dr E Borges Road, Parel, Mumbai, 400012, India.
Otolaryngologic clinics of North America
|October 28, 2025
概括
新的新辅助策略,包括化学免疫疗法和免疫检查点抑制剂,正在探索头癌. 虽然有前途,但亡蛋白抗剂的抑制剂尚未证明III期益处.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 头部和部癌症研究研究
背景情况:
- 细胞毒性化疗在头支状细胞癌 (HNSCC) 的新辅助治疗中所扮演的既定角色是有限的,主要是保护喉.
- 较旧的研究没有足够的证据证明广泛的新辅助化学疗法使用.
研究的目的:
- 探索HNSCC新的新辅助治疗策略.
- 评估新兴疗法在外科手术前的潜力.
主要方法:
- 研究将免疫检查点抑制剂 (ICI) 纳入新辅助/术后治疗方案的研究.
- 探索化疗与ICI和/或计量学疗法的新组合.
- 评估新辅助化学免疫疗法对辐射疗法的响应适应降级.
主要成果:
- 免疫检查点抑制剂正在被整合到新辅助和外科外科设置中.
- 化学疗法与ICI和计量学疗法的组合正在研究中.
- 新辅助化学免疫疗法正在研究为量身定制的放射疗法降级.
- 亡蛋白抑制剂 (IAP) 抗剂虽然受到研究,但在HNSCC的III期试验中没有显示出有效性.
结论:
- 新的新辅助方法,特别是那些涉及免疫治疗的方法,是HNSCC的重要研究领域.
- 目前的证据表明,IAP抗剂在HNSCC.的III期设置中尚未有效.
- 未来的研究方向包括优化化疗-免疫疗法组合和响应适应的治疗降级.
更多相关视频
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


